CVS Health also reported an operating loss of $1.59 billion for the second quarter of the year. Forte Capital LLC ADV now owns 51,033 shares of the pharmacy operator's stock worth $3,284,000 after acquiring an additional 1,917 shares during the period.
CVS Health says it passes well over 90 percent of its rebates on to its customers, and Merlo added Wednesday that the idea that what it retains affects prescription drug prices is "entirely false". The stock increased 4.20% or $2.7505 during the last trading session, reaching $68.2005. The company has a quick ratio of 1.88, a current ratio of 2.37 and a debt-to-equity ratio of 1.59.
Union Bankshares Corp decreased Cvs Health Corp (CVS) stake by 26.79% reported in 2018Q1 SEC filing. During the initial phase of testing, a CVS Health study found that 95 percent of patients who opted to receive a telehealth visit were highly satisfied with the quality of care they received. The stock has "Buy" rating by Bank of America on Wednesday, April 11. ValuEngine downgraded CVS Health from a "sell" rating to a "strong sell" rating in a research note on Tuesday, May 8th. Leerink Swann set a $85.00 target price on CVS Health and gave the stock a "buy" rating in a research note on Tuesday, April 10th. The firm has "Overweight" rating given on Tuesday, July 3 by Morgan Stanley. CVS Health now has a consensus rating of "Buy" and an average price target of $85.74.
The company also raised the lower end of its 2018 adjusted earnings forecast to $6.98 to $7.08 per share from its previous forecast of $6.87 to $7.08 per share.
The Woonsocket, R.I. -based company's second-quarter revenue rose 2.2% to $46.71 billion, beating the $46.34 billion analysts polled by Thomson Reuters were looking for. Investors of record on Wednesday, July 25th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.97%.
MinuteClinic Video Visits rely on a virtual care technology platform by Teledoc to provide patients with customized service through the CVS Pharmacy app. Cvs Health Corp now has $66.54B valuation. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
"We believe that competition within each of the business segments in which we operate pharmacy benefit management, pharmacies and insurers is fierce and will remain so", the company said in a statement.